Skip to main content

Table 1 Age, duration of treatment, and biochemical and pharmacological parameters (n = 90)

From: Associations between tamoxifen, estrogens, and FSH serum levels during steady state tamoxifen treatment of postmenopausal women with breast cancer

Variables Median [Range]
Age 62 [48-85] Year
Tamoxifen duration 571 [84-4380] Days
E21 9.4 [1.3 - 54.7] pmol/L
E1 98.6 [29.3 - 355.6] pmol/L
E1S 582 [30-2923] pmol/L
FSH 38.2 [20.3 - 108.0] IU/L
SHBG 81 [27-173] nmol/L
Tam 96 [31-247] ng/ml
4OHtam 5.8 [2.7 - 17.2] ng/ml
4OHNDtam 50.7 [25.1 - 184.8] ng/ml
NDtam 230 [116-596] ng/ml
NDDtam 39.8 [15.7 - 93.4] ng/ml
tamNox 9.6 [3.5 - 37.9] ng/ml
  1. 1E2, estradiol; E1, estrone; E1S, estrone sulfate; FSH, follicle stimulating hormone; SHBG, sex hormone binding globulin; tam, tamoxifen; 4OHtam, 4-hydroxytamoxifen; 4OHNDtam, 4-hydroxy-N-demethyltamoxifen; NDtam, N-demethyltamoxifen; NDDtam, N-dedimethyltamoxifen; tamNox, tamoxifen-N-oxide.